Financial Perspectives’s West Pharmaceutical WST Stock Holding History

Financial Perspectives’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.78K	Hold	27	–	–	﹤0.01%	549
2026 Q1	$6.82K	Hold	27	–	–	﹤0.01%	564
2025 Q4	$7.48K	Hold	27	–	–	﹤0.01%	550
2025 Q3	$7.13K	Hold	27	–	–	﹤0.01%	550
2025 Q2	$5.94K	Hold	27	–	–	﹤0.01%	560
2025 Q1	$6.07K	Hold	27	–	–	﹤0.01%	551
2024 Q4	$8.88K	Hold	27	–	–	﹤0.01%	519
2024 Q3	$8.13K	Hold	27	–	–	﹤0.01%	492
2024 Q2	$8.92K	Hold	27	–	–	﹤0.01%	477
2024 Q1	$10.7K	Hold	27	–	–	﹤0.01%	452
2023 Q4	$9.54K	Hold	27	–	–	﹤0.01%	473
2023 Q3	$10.2K	Hold	27	–	–	﹤0.01%	448
2023 Q2	$10.4K	Hold	27	–	–	﹤0.01%	445
2023 Q1	$9.39K	Hold	27	–	–	﹤0.01%	450
2022 Q4	$6.38K	Hold	27	–	–	﹤0.01%	490
2022 Q3	$6.67K	Hold	27	–	–	﹤0.01%	480
2022 Q2	$8.19K	Hold	27	–	–	﹤0.01%	463
2022 Q1	$11.1K	Hold	27	–	–	0.01%	448
2021 Q4	$12.7K	Hold	27	–	–	0.01%	417
2021 Q3	$11.5K	Hold	27	–	–	0.01%	428
2021 Q2	$9.73K	Hold	27	–	–	﹤0.01%	463
2021 Q1	$7.63K	Hold	27	–	–	﹤0.01%	463
2020 Q4	$7.67K	Hold	27	–	–	﹤0.01%	427
2020 Q3	$7.45K	Hold	27	–	–	﹤0.01%	391
2020 Q2	$6.15K	Hold	27	–	–	﹤0.01%	393
2020 Q1	$4.12K	Hold	27	–	–	﹤0.01%	395
2019 Q4	$4.07K	Buy	+27	New	+$3.93K	﹤0.01%	411

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Financial Perspectives's WST Position: Q2 2026 in Review

Financial Perspectives held its West Pharmaceutical (WST) position steady in Q2 2026 at 27 shares worth $9.78K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Financial Perspectives first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.7K in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Financial Perspectives held 27 shares of West Pharmaceutical worth $9.78K as of Q2 2026.
Financial Perspectives left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Financial Perspectives's portfolio in Q2 2026, its #549 holding.
Financial Perspectives first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
Financial Perspectives's West Pharmaceutical position peaked at $12.7K in Q4 2021.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.